TRANSLARNA Trademark

Trademark Overview

On Thursday, June 25, 2020, a trademark application was filed for TRANSLARNA with the United States Patent and Trademark Office. The USPTO has given the TRANSLARNA trademark a serial number of 90020103. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 4, 2024. This trademark is owned by PTC Therapeutics, Inc.. The TRANSLARNA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of genetic disorders
translarna

General Information

Serial Number90020103
Word MarkTRANSLARNA
Filing DateThursday, June 25, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 8, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of genetic disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 22, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePTC Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth Plainfield, NJ 07080
Party NamePTC Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth Plainfield, NJ 07080

Trademark Events

Event DateEvent Description
Monday, March 4, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 4, 2024ABANDONMENT - NO USE STATEMENT FILED
Wednesday, November 1, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, October 30, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, August 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 7, 2023SOU EXTENSION 5 GRANTED
Monday, July 31, 2023SOU EXTENSION 5 FILED
Monday, August 7, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 31, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, January 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 9, 2023SOU EXTENSION 4 GRANTED
Monday, January 9, 2023SOU EXTENSION 4 FILED
Monday, January 9, 2023SOU TEAS EXTENSION RECEIVED
Saturday, July 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 14, 2022SOU EXTENSION 3 GRANTED
Thursday, July 14, 2022SOU EXTENSION 3 FILED
Thursday, July 14, 2022SOU TEAS EXTENSION RECEIVED
Saturday, January 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 13, 2022SOU EXTENSION 2 GRANTED
Thursday, January 13, 2022SOU EXTENSION 2 FILED
Thursday, January 13, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 27, 2021SOU EXTENSION 1 GRANTED
Tuesday, July 27, 2021SOU EXTENSION 1 FILED
Tuesday, July 27, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, February 2, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 8, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 8, 2020PUBLISHED FOR OPPOSITION
Wednesday, November 18, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 2, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, October 24, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 23, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 23, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 22, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 22, 2020NON-FINAL ACTION E-MAILED
Tuesday, September 22, 2020NON-FINAL ACTION WRITTEN
Wednesday, September 16, 2020ASSIGNED TO EXAMINER
Wednesday, July 22, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 29, 2020NEW APPLICATION ENTERED

Related Keywords

translarna disorders genetic treatment preparations pharmaceutical